ViaDerma Stock Price, News & Analysis (OTCMKTS:VDRM) 0.01 +0.00 (+3.00%) (As of 12/7/2023 09:07 PM ET) Add Compare Share Share Today's Range0.01▼0.0150-Day Range0.01▼0.0152-Week Range0.00▼0.03Volume111,400 shsAverage Volume3.35 million shsMarket CapitalizationN/AP/E Ratio0.00Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest About ViaDerma Stock (OTCMKTS:VDRM)ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.Read More VDRM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VDRM Stock News HeadlinesOctober 24, 2023 | finance.yahoo.comViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & MoreJuly 6, 2023 | finance.yahoo.comViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & MoreDecember 8, 2023 | Edge On The Street (Ad)The Battery Metal Nobody Told You AboutAccording to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech." April 18, 2023 | finance.yahoo.comViaDerma, Inc. (VDRM) Stock Historical Prices & Data - Yahoo FinanceMarch 16, 2023 | finance.yahoo.comViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth ProductMarch 8, 2023 | finance.yahoo.comViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth ProductMarch 2, 2023 | finance.yahoo.comViaDerma Provides an Update on Current & Future Business ActivitiesJanuary 12, 2023 | benzinga.comViaDerma Retains Digital Marketing Leader INTENT SCIENCES to Accelerate Business Growth OnlineDecember 8, 2023 | Edge On The Street (Ad)The Battery Metal Nobody Told You AboutAccording to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech." September 15, 2022 | finance.yahoo.comViaDerma Successfully Completes Quality Control Testing of its New Vitastem ProductsJune 22, 2022 | finance.yahoo.comViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem ProductsApril 1, 2022 | nz.finance.yahoo.comAvoteo emerges as the first crowdfunding platform without spending moneyApril 1, 2022 | yahoo.comVictoria and David Beckham's UK home 'burgled' while daughter Harper was asleep upstairsApril 1, 2022 | yahoo.comOur existence isn't new, but now transgender people are visible like never beforeMarch 31, 2022 | finance.yahoo.comViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous YearOctober 4, 2021 | finance.yahoo.comViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem UltraAugust 24, 2021 | finance.yahoo.comViaDerma, Inc. Files Amended Financial StatementsAugust 21, 2021 | barrons.comViaDerma Inc.See More Headlines Receive VDRM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ViaDerma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today12/07/2023Next Earnings (Estimated)12/15/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:VDRM CUSIPN/A CIKN/A Webviadermalicensing.com Phone(310) 734-6111FaxN/AEmployees75Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Qing Hua Lin (Age 42)Chief Financial Officer and Director Comp: $4.46kMr. Baotang Zhao (Age 45)Chief Sales Officer Comp: $28.77kMr. Zhang Xie (Age 44)Corporate Secretary and Director Comp: $9.18kDr. Christopher A OtikoFounder, Chief Executive Officer and PresidentDr. Andrew Berman M.D.MPH, Medical Director and Member of Advisory BoardKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors VDRM Stock Analysis - Frequently Asked Questions How have VDRM shares performed in 2023? ViaDerma's stock was trading at 0.01 at the beginning of the year. Since then, VDRM stock has increased by 66.1% and is now trading at 0.01. View the best growth stocks for 2023 here. When is ViaDerma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, December 15th 2023. View our VDRM earnings forecast. How do I buy shares of ViaDerma? Shares of VDRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:VDRM) was last updated on 12/8/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViaDerma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.